Halyard Health, Inc. is a medical technology company. The Company operates through two segments: Medical Devices and Surgical and Infection Prevention (S&IP). The Medical Devices segment provides a portfolio of product offerings focused on pain management, respiratory and digestive health. The S&IP segment provides healthcare supplies and solutions that target the prevention of healthcare-associated infections. The Company address healthcare needs, such as reducing the use of opioids, while helping patients move from surgery to recovery. The Medical Devices segment's products include post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems and enteral feeding tubes. The S&IP segment includes product offerings, such as sterilization wrap, surgical drapes and gowns, facial protection, protective apparel and medical exam gloves.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Instruments & Supplies
- Sub-Industry: N/A
- Symbol: NYSE:HYH
- CUSIP: N/A
- Web: www.halyardhealth.com
- Market Cap: $1.69 billion
- Outstanding Shares: 46,700,000
- 50 Day Moving Avg: $37.52
- 200 Day Moving Avg: $38.03
- 52 Week Range: $29.84 - $41.84
Sales & Book Value:
- Trailing P/E Ratio: 44.07
- Foreward P/E Ratio: 17.74
- P/E Growth: 4.63
- Annual Revenue: $1.6 billion
- Price / Sales: 1.06
- Book Value: $24.22 per share
- Price / Book: 1.49
- EBIDTA: $166.4 million
- Net Margins: 2.80%
- Return on Equity: 8.63%
- Return on Assets: 4.54%
- Debt-to-Equity Ratio: 0.54%
- Current Ratio: 1.95%
- Quick Ratio: 0.99%
- Average Volume: 378,202 shs.
- Beta: 1.87
- Short Ratio: 11.42
Frequently Asked Questions for Halyard Health (NYSE:HYH)
What is Halyard Health's stock symbol?
Halyard Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "HYH."
How were Halyard Health's earnings last quarter?
Halyard Health Inc (NYSE:HYH) announced its earnings results on Tuesday, May, 2nd. The company reported $0.48 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.43 by $0.05. The firm earned $395.60 million during the quarter, compared to analyst estimates of $391.56 million. Halyard Health had a return on equity of 8.63% and a net margin of 2.80%. The business's revenue was up 2.8% compared to the same quarter last year. During the same quarter in the prior year, the company earned $0.53 EPS. View Halyard Health's Earnings History.
What guidance has Halyard Health issued on next quarter's earnings?
Halyard Health updated its FY17 earnings guidance on Tuesday, May, 2nd. The company provided earnings per share (EPS) guidance of $1.70 - $2.00 for the period, compared to the Thomson Reuters consensus estimate of $1.84.
Where is Halyard Health's stock going? Where will Halyard Health's stock price be in 2017?
4 analysts have issued 1-year price objectives for Halyard Health's stock. Their predictions range from $35.00 to $45.00. On average, they expect Halyard Health's stock price to reach $39.33 in the next twelve months. View Analyst Ratings for Halyard Health.
What are analysts saying about Halyard Health stock?
Here are some recent quotes from research analysts about Halyard Health stock:
- 1. According to Zacks Investment Research, "Halyard Health, Inc. is a medical technology company. It is focused on advancing health and healthcare by preventing infection, eliminating pain and speeding recovery. The Company sells surgical and infection prevention products for the operating room. Halyard offers products such as sterilization wraps, face masks, surgical drapes and gowns, closed suction catheters, pain pumps and enteral feeding tubes. It offers a range of medical device solutions including post-operative pain management solutions, minimally invasive interventional (or chronic) pain therapies, closed airway suction systems, and enteral feeding tubes. Halyard Health, Inc. is headquartered in Alpharetta, Georgia. " (5/4/2017)
- 2. Stifel Nicolaus analysts commented, "HYH closed 2016 with its fourth consecutive quarter of sales and EPS upside relative to both Consensus and management guidance. After a more difficult than expected first-year (2015) post-spin, in 2016, the company's transformation took clearer shape and was highlighted by: accretive M&A, a positive mix shift to the more profitable Medical Device franchise (38% of sales; 64% of operating profit), successful re-negotiations of material GPO contracts, significant organic cost-savings and stepped-up investments, all with significantly improved cash flow generation ($100M+ guide vs. $160M actual). We continue to believe HYH has further price appreciation potential ahead as '2016-like' thematic drivers continue playing out over the next 12-24 months. Still, we acknowledge that HYH shares (+56% TTM vs. S&P500: +23%) trading at 20x 2018E EPS (vs. large cap ~18x) could "pause" here as the stock absorbs the recent out-performance and the next wave of potentially positive catalysts becomes more visible. Yet to be realized sales, margin, and EPS-enhancing catalysts could include: IT cost savings, better S&IP pricing, more normal nitrile pricing and most important, further accretive M&A opportunities. Company-specific 2017 headwinds could include: more intense commodity price inflation, stepped up On-Q competition, and still uncertain macro tax-related legislation. For us, the bottom line is that HYH remains a positive long-term transformation story that is still in 'early innings' with significant opportunity both organically and through acquisitions to leverage earnings. We rate HYH Buy and raise our TP to $45 (from $38)." (2/28/2017)
Who are some of Halyard Health's key competitors?
Some companies that are related to Halyard Health include ICU Medical, Incorporated (ICUI), ProShares UltraShort DJ-UBS Commodity (CMD), Insulet (PODD), Haemonetics (HAE), Inogen (INGN), Merit Medical Systems (MMSI), Glaukos Corp (GKOS), Mazor Robotics Ltd - (MZOR), Luminex (LMNX), OraSure Technologies (OSUR), AtriCure (ATRC), AngioDynamics (ANGO), LeMaitre Vascular (LMAT), Endologix (ELGX), Antares Pharma (ATRS), STAAR Surgical Company (STAA), Entellus Medical (ENTL) and ConforMIS (CFMS).
Who owns Halyard Health stock?
Halyard Health's stock is owned by a number of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (12.74%), Vanguard Group Inc. (9.33%), Dimensional Fund Advisors LP (5.63%), State Street Corp (3.39%), Paradice Investment Management LLC (3.11%) and Shapiro Capital Management LLC (2.84%). Company insiders that own Halyard Health stock include Robert E Abernathy and Steven E Voskuil. View Institutional Ownership Trends for Halyard Health.
Who sold Halyard Health stock? Who is selling Halyard Health stock?
Halyard Health's stock was sold by a variety of institutional investors in the last quarter, including Shapiro Capital Management LLC, Cove Street Capital LLC, Morgan Stanley, Alliancebernstein L.P., Chicago Equity Partners LLC, Cornerstone Capital Management Holdings LLC., Ameriprise Financial Inc. and Northpointe Capital LLC. View Insider Buying and Selling for Halyard Health.
Who bought Halyard Health stock? Who is buying Halyard Health stock?
Halyard Health's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Copper Rock Capital Partners LLC, Dimensional Fund Advisors LP, Vanguard Group Inc., Credit Agricole S A, Bank of New York Mellon Corp, Schwab Charles Investment Management Inc. and Piermont Capital Management Inc.. Company insiders that have bought Halyard Health stock in the last two years include Robert E Abernathy and Steven E Voskuil. View Insider Buying and Selling for Halyard Health.
How do I buy Halyard Health stock?
Shares of Halyard Health can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of Halyard Health stock cost?
One share of Halyard Health stock can currently be purchased for approximately $36.18.
Earnings History for Halyard Health (NYSE:HYH)Earnings History by Quarter for Halyard Health (NYSE:HYH)
(Data available from 1/1/2011 forward)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|5/2/2017||Q1 2017||$0.43||$0.48||$391.56 million||$395.60 million||View||Listen|
|2/27/2017||Q416||$0.44||$0.50||$401.72 million||$410.00 million||View||Listen|
|11/2/2016||Q316||$0.39||$0.48||$387.64 million||$398.00 million||View||N/A|
|8/3/2016||Q216||$0.36||$0.45||$383.08 million||$400.00 million||View||N/A|
|5/4/2016||Q116||$0.34||$0.53||$369.80 million||$385.00 million||View||N/A|
|2/29/2016||Q415||$0.50||$0.57||$401.96 million||$401.40 million||View||Listen|
|11/3/2015||Q315||$0.47||$0.52||$388.00 million||$390.00 million||View||N/A|
|8/4/2015||Q215||$0.53||$0.52||$401.70 million||$389.30 million||View||N/A|
|5/4/2015||Q1 2015||$0.64||$0.51||$390.00 million||$394.00 million||View||N/A|
|3/4/2015||Q4||$0.75||$1.59||$425.10 million||$439.40 million||View||N/A|
Earnings Estimates for Halyard Health (NYSE:HYH)
2017 EPS Consensus Estimate: $1.81
(Data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Halyard Health (NYSE:HYH)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading and Institutional Ownership History for Halyard Health (NYSE:HYH)
Insider Ownership Percentage: 1.20%Insider Trades by Quarter for Halyard Health (NYSE:HYH)
Institutional Ownership Percentage: 87.50%
(Data available from 1/1/2013 forward)
|Transaction Date||Insider Name||Title||Buy/Sell||Number of Shares||Average Share Price||Total Transaction||Details|
|9/4/2015||Robert E Abernathy||CEO||Buy||10,000||$31.06||$310,600.00|| |
|9/1/2015||Steven E Voskuil||CFO||Buy||1,000||$30.00||$30,000.00|| |
Headline Trends for Halyard Health (NYSE:HYH)
Latest Headlines for Halyard Health (NYSE:HYH)
|Halyard Health (HYH) Expands CORGRIP System Product Line - Nasdaq|
www.nasdaq.com - May 24 at 5:38 PM
|Halyard Health (HYH) Presents At Bank of America Merrill Lynch 2017 Health Care Conference - Slideshow|
seekingalpha.com - May 23 at 5:23 PM
|Halyard Health Introduces Expanded Sizes for CORGRIP* NG/NI Tube Retention System|
finance.yahoo.com - May 22 at 10:57 AM
|Halyard Health (HYH) & Sustainable Solutions Announce Licensing Agreement for Hospital Products from Recycled ... - StreetInsider.com|
www.streetinsider.com - May 19 at 10:21 AM
|Halyard Health (HYH) & Sustainable Solutions Announce Licensing Agreement for Hospital Products from Recycled Sterilization Wrap|
www.streetinsider.com - May 18 at 9:31 AM
|Halyard Health and Sustainable Solutions Enter Licensing Agreement to Create Environmentally Conscious Hospital Products from Recycled Sterilization Wrap|
finance.yahoo.com - May 18 at 9:31 AM
|Halyard Health Adds New Drainage System to Comprehensive Portfolio of Enteral Feeding Products|
finance.yahoo.com - May 16 at 11:14 AM
|Halyard Health, Inc. to Present at Bank of America Merrill Lynch 2017 Healthcare Conference|
finance.yahoo.com - May 11 at 6:25 PM
|Halyard Health and the ALS Association Team Up for 2017 Advocacy Conference|
finance.yahoo.com - May 10 at 1:28 PM
|ETFs with exposure to Halyard Health, Inc. : May 8, 2017|
finance.yahoo.com - May 8 at 5:30 PM
|Halyard Health Inc (HYH) Rating Lowered to C at TheStreet|
www.americanbankingnews.com - May 6 at 11:52 PM
|Halyard Health Inc (HYH) Receives $39.33 Average Target Price from Analysts|
www.americanbankingnews.com - May 5 at 10:58 PM
|Halyard Health, Inc. :HYH-US: Earnings Analysis: Q1, 2017 By the Numbers : May 5, 2017|
finance.yahoo.com - May 5 at 5:47 PM
|Q2 2017 Earnings Forecast for Halyard Health Inc (HYH) Issued By KeyCorp|
www.americanbankingnews.com - May 5 at 8:28 AM
|Halyard Health Inc (HYH) Cut to "Hold" at Zacks Investment Research|
www.americanbankingnews.com - May 5 at 12:04 AM
|Halyard Health's (HYH) CEO Robert Abernathy on Q1 2017 Results - Earnings Call Transcript - Seeking Alpha|
seekingalpha.com - May 4 at 5:59 PM
|Edited Transcript of HYH earnings conference call or presentation 2-May-17 1:00pm GMT|
finance.yahoo.com - May 3 at 10:26 PM
|Halyard Health (HYH) Shares Cross Below 200 DMA|
www.nasdaq.com - May 3 at 5:25 PM
|Kimberly-Clark Sues Halyard Over $454 Million Gown Verdict|
finance.yahoo.com - May 3 at 5:25 PM
|Halyard Health (HYH) Receives News Sentiment Score of 0.43|
www.americanbankingnews.com - May 3 at 10:34 AM
|Halyard Health Inc (HYH) Given Consensus Rating of "Hold" by Brokerages|
www.americanbankingnews.com - May 2 at 8:26 PM
|Halyard Health Inc (HYH) Issues Quarterly Earnings Results|
www.americanbankingnews.com - May 2 at 4:34 PM
|Halyard Health Inc (HYH) Releases FY17 Earnings Guidance|
www.americanbankingnews.com - May 2 at 10:46 AM
|Halyard Health, Inc. Announces First Quarter 2017 Results|
finance.yahoo.com - May 2 at 10:19 AM
|Halyard beats Street 1Q forecasts|
finance.yahoo.com - May 2 at 10:19 AM
|Halyard Health Inc (HYH) Expected to Post Quarterly Sales of $391.86 Million|
www.americanbankingnews.com - April 30 at 8:34 AM
|Halyard Health (HYH) Given News Sentiment Rating of 0.56|
www.americanbankingnews.com - April 29 at 9:48 AM
|$0.43 EPS Expected for Halyard Health Inc (HYH) This Quarter|
www.americanbankingnews.com - April 28 at 6:06 PM
|Halyard Health, Inc. – Value Analysis (NYSE:HYH) : April 27, 2017|
finance.yahoo.com - April 27 at 6:23 PM
|Halyard Health, Inc. to Present at Deutsche Bank Health Care Conference - PR Newswire (press release)|
www.prnewswire.com - April 27 at 8:32 AM
|Halyard Health, Inc. to Present at Deutsche Bank Health Care Conference|
finance.yahoo.com - April 26 at 7:33 PM
|Halyard Health, Inc. breached its 50 day moving average in a Bullish Manner : HYH-US : April 26, 2017|
finance.yahoo.com - April 26 at 7:33 PM
|Halyard Health (HYH) Given Media Impact Rating of 0.48|
www.americanbankingnews.com - April 25 at 10:11 AM
|Halyard Health (HYH) Given Daily News Impact Rating of 0.56|
www.americanbankingnews.com - April 22 at 7:47 AM
|Halyard Health, Inc. -- Moody's: California Jury Award Is Credit Negative For Halyard Health|
finance.yahoo.com - April 21 at 5:44 PM
|FDA Clears Halyard Health's COOLIEF* for the Management of Osteoarthritis Knee Pain|
finance.yahoo.com - April 20 at 11:35 AM
|Halyard Health (HYH) Receives Media Impact Score of 0.44|
www.americanbankingnews.com - April 19 at 12:37 PM
|Halyard Health, Inc. To Webcast Conference Call Discussing First Quarter 2017 Financial Results|
finance.yahoo.com - April 18 at 11:09 AM
|Halyard Health (HYH) Earns Daily Media Impact Score of 0.56|
www.americanbankingnews.com - April 16 at 8:12 AM
|Moody's: California Jury Award Is Credit Negative For Halyard Health|
finance.yahoo.com - April 14 at 5:48 PM
|Halyard Health (HYH) Earns Media Sentiment Rating of 0.56|
www.americanbankingnews.com - April 13 at 8:28 AM
|Jury Hits Kimberly-Clark and Halyard Health with $454 Million Fraud Verdict over Sale of Defective Medical Devices Announces Eagan Avenatti, LLP|
finance.yahoo.com - April 10 at 5:29 PM
|Halyard Health hit with $100 million in damages in court case|
www.bizjournals.com - April 10 at 11:06 AM
|Halyard Health Inc (HYH) Stock Rating Upgraded by TheStreet|
www.americanbankingnews.com - April 9 at 10:51 PM
| Analysts Anticipate Halyard Health Inc (HYH) Will Announce Earnings of $0.43 Per Share|
www.americanbankingnews.com - April 7 at 6:36 PM
|Halyard Health Inc (HYH) Lifted to Hold at Zacks Investment Research|
www.americanbankingnews.com - April 5 at 11:43 PM
|Halyard Health Inc (HYH) Given Average Rating of "Hold" by Analysts|
www.americanbankingnews.com - April 5 at 6:03 PM
|Zacks Investment Research Lowers Halyard Health Inc (HYH) to Sell|
www.americanbankingnews.com - April 1 at 3:30 PM
|Halyard Health Inc (HYH) Upgraded to Hold by Zacks Investment Research|
www.americanbankingnews.com - March 23 at 12:58 AM
|Halyard Health (HYH) Presents At The Raymond James 38th Annual Institutional Investors Conference 2017 - Slideshow|
seekingalpha.com - March 9 at 1:08 AM
Halyard Health (HYH) Chart for Thursday, May, 25, 2017